Unique Technology Edge Levita's MARS platform represents a unique, first-of-its-kind approach that combines magnetic surgery with advanced machinery to minimize invasiveness and footprint. The value proposition targets hospitals and surgeons seeking improved patient outcomes, shorter recovery times, and operational efficiency in the OR. This differentiation supports direct outreach to MIS programs, surgical centers of excellence, and hospital procurement teams evaluating next-generation minimally invasive solutions.

US Market Expansion Strong US growth momentum is underscored by a 2022 Series C financing of 26 million dollars to advance regulatory clearance and near-term commercialization in the United States. With a 2016 product launch and ongoing clinical adoption, there is a clear path for broader US market access. Business development opportunities include regulatory-aligned partnerships, hospital systems with high MIS volumes, and distribution arrangements that accelerate market entry.

Clinical Validation Milestones Clinical validation includes published data in 2019 and the milestone of the 1,000th Magnetic Surgery procedure by 2021, providing credible evidence for ROI to surgeons and payers. These data points enable evidence-based discussions with surgical leaders and administrators about cost-of-care improvements and patient outcomes, helping to de-risk new adoption.

Leadership and Scale Leadership changes, including the appointment of Maria Sainz as Chairwoman in 2022, along with a lean team, suggest a strategic path to scale through partnerships and channel programs. This presents opportunities for co-development deals, distributor arrangements, and collaborative trials with larger health systems and academic centers.

Trust and Compliance Security and trust considerations are important given reports of fraudulent recruitment messages; ensure outreach is conducted through official domains and formal procurement channels. Emphasize compliant, verified engagement with hospital procurement teams and RFP processes to build credibility and reduce risk in vendor selection.